These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16809213)

  • 21. Botulinum toxin in tension-type headache.
    Relja M; Telarović S
    J Neurol; 2004 Feb; 251 Suppl 1():I12-4. PubMed ID: 14991337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anterior knee pain caused by patellofemoral pain syndrome can be relieved by Botulinum toxin type A injection.
    Chen JT; Tang AC; Lin SC; Tang SF
    Clin Neurol Neurosurg; 2015 Feb; 129 Suppl 1():S27-9. PubMed ID: 25683309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study.
    Schulte-Mattler WJ; Krack P;
    Pain; 2004 May; 109(1-2):110-4. PubMed ID: 15082132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study.
    Bily W; Trimmel L; Mödlin M; Kaider A; Kern H
    Arch Phys Med Rehabil; 2008 Jul; 89(7):1230-6. PubMed ID: 18586125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enduring efficacy of Botulinum toxin type A injection for refractory anterior knee pain.
    Silbert BI; Singer BJ; Silbert PL; Gibbons JT; Singer KP
    Disabil Rehabil; 2012; 34(1):62-8. PubMed ID: 21936736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental knee joint pain during strength training and muscle strength gain in healthy subjects: a randomized controlled trial.
    Sørensen TJ; Langberg H; Hodges PW; Bliddal H; Henriksen M
    Arthritis Care Res (Hoboken); 2012 Jan; 64(1):108-16. PubMed ID: 21905254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patellar taping affects vastus medialis obliquus activation in subjects with patellofemoral pain before and after quadriceps muscle fatigue.
    Ng GY; Wong PY
    Clin Rehabil; 2009 Aug; 23(8):705-13. PubMed ID: 19482890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of a weight-bearing rehabilitation program for patients diagnosed with patellofemoral pain syndrome.
    Boling MC; Bolgla LA; Mattacola CG; Uhl TL; Hosey RG
    Arch Phys Med Rehabil; 2006 Nov; 87(11):1428-35. PubMed ID: 17084115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A controlled trial of weight-bearing versus non-weight-bearing exercises for patellofemoral pain.
    Herrington L; Al-Sherhi A
    J Orthop Sports Phys Ther; 2007 Apr; 37(4):155-60. PubMed ID: 17469667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of patellar taping on vasti onset timing, knee kinematics, and kinetics in asymptomatic individuals with a delayed onset of vastus medialis oblique.
    Bennell K; Duncan M; Cowan S
    J Orthop Res; 2006 Sep; 24(9):1854-60. PubMed ID: 16838377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relevance of botulinum toxin injection and nerve block of rectus femoris to kinematic and functional parameters of stiff knee gait in hemiplegic adults.
    Robertson JV; Pradon D; Bensmail D; Fermanian C; Bussel B; Roche N
    Gait Posture; 2009 Jan; 29(1):108-12. PubMed ID: 18771925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
    Lundy CT; Doherty GM; Fairhurst CB
    Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of chronic low back pain with successive injections of botulinum toxin a over 6 months: a prospective trial of 60 patients.
    Ney JP; Difazio M; Sichani A; Monacci W; Foster L; Jabbari B
    Clin J Pain; 2006 May; 22(4):363-9. PubMed ID: 16691090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache.
    de Ru JA; Buwalda J
    J Laryngol Otol; 2009 Apr; 123(4):412-7. PubMed ID: 18588738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional and EMG responses to a physical therapy treatment in patellofemoral syndrome patients.
    Sacco Ide C; Konno GK; Rojas GB; Arnone AC; Pássaro Ade C; Marques AP; Cabral CM
    J Electromyogr Kinesiol; 2006 Apr; 16(2):167-74. PubMed ID: 16102978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of phantom pain with botulinum-toxin A. A pilot study].
    Kern U; Martin C; Scheicher S; Müller H
    Schmerz; 2003 Apr; 17(2):117-24. PubMed ID: 12695892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
    Sahai A; Dowson C; Khan MS; Dasgupta P
    BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Botulinum Toxin Type A in the Clinical Management of Refractory Anterior Knee Pain.
    Singer BJ; Silbert BI; Silbert PL; Singer KP
    Toxins (Basel); 2015 Aug; 7(9):3388-404. PubMed ID: 26308056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia.
    Tassorelli C; Mancini F; Balloni L; Pacchetti C; Sandrini G; Nappi G; Martignoni E
    Mov Disord; 2006 Dec; 21(12):2240-3. PubMed ID: 17029278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional outcomes of intramuscular botulinum toxin type a and occupational therapy in the upper limbs of children with cerebral palsy: a randomized controlled trial.
    Wallen M; O'Flaherty SJ; Waugh MC
    Arch Phys Med Rehabil; 2007 Jan; 88(1):1-10. PubMed ID: 17207668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.